2026 Information and Registration Coming Soon!
The ACCP Precision Medicine: Applied Pharmacogenomics Certificate Program is an interactive, practice-based program designed to help clinical pharmacists understand how genetic factors influence the efficacy and adverse effects of drug therapy.
22 Contact Hours (2.2 CEU) –
ACPE UAN: 0217-0000-25-203-B04-P;
ACPE CPN: 0217-25-001-CP
Target Audience: Pharmacists
Goals: Participants will learn empirical strategies for applying pharmacogenomics knowledge in a clinical setting.
- Explain fundamental genetic and pharmacogenomic concepts using appropriate nomenclature and terminology.
- Describe how genetic variation influences drug pharmacokinetics, pharmacodynamics, and clinical outcomes.
- Educate patients and health care professionals on key principles of clinical pharmacogenomics, including clinical utility, cost-effectiveness, reimbursement considerations, and ethical, legal, and social implications of pharmacogenomic testing.
- Identify appropriate clinical scenarios for recommending clinical pharmacogenomic testing.
- Interpret pharmacogenomic test results to guide evidence-based drug selection and individualized dosing strategies.
- Formulate patient-specific pharmacotherapy recommendations based on pharmacogenomic test results, evidence-based guidelines, scientific literature, and other relevant patient factors.
- Effectively communicate pharmacogenomic-informed recommendations to the health care team to optimize patient care.
- Evaluate potential barriers and drivers to pharmacogenomic adoption within diverse healthcare settings.
- Design a pharmacogenomics implementation plan for clinical practice, including assessment of institutional resources such as clinical informatics and decision support systems.
The learner must complete:
- The asynchronous didactic component of the program consists of fourteen (14) recorded self-study lectures. Lecture modules will be released on Tuesdays as per the course schedule.
- The fourteen lectures will provide sixteen (16) total hours of contact time and continuing education credit in the core asynchronous portion of the program.
- The ‘live’ virtual hands-on component of the program will be delivered via Zoom. The ‘live’ sessions will consist of six (6) total hours of case-based interactive sessions designed to demonstrate the application of the program competencies. Participants are expected to participate in each ‘live’ Zoom session.
The ‘live’ Zoom sessions will occur on Tuesdays at 7:00 pm EST. (attendance is required at all ‘live’ sessions). Specific dates are listed below:
- Tuesday, September 30, 2025, 7:00 to 8:30 pm ET
- Tuesday, October 21, 2025, 7:00 to 8:30 pm ET
- Tuesday, November 4, 2025, 7:00 to 8:30 pm ET
- Tuesday, November 18, 2025, 7:00 to 8:30 pm ET
- Tuesday, November 25, 2025, 7:00 to 8:30 pm ET
- Activity Evaluation
- Participant Evaluation
|
Module Name
|
Date (virtual session or module release)
|
Topics
|
On-Demand Videos (hrs)
|
Live “Virtual” Sessions (hrs)
|
|
PGx 101
|
9/9/2025
|
Lecture 1: Intro to Genetics and PGx (pharmacogenes, benefits, limitations, etc)
|
1
|
|
|
PGx Resources
|
9/9/2025
|
Lecture 2: How to review evidence, guidelines, resources, etc.
|
1
|
|
|
Cardiology
|
9/16/2025
|
Lecture 3: Clopidogrel, warfarin, statins
|
2
|
|
|
Drug-Induced Hypersensitivity
|
9/23/2025
|
Lecture 4: Carbamazepine, oxcarbazepine, allopurinol, phenytoin
|
1
|
|
|
Applied Clinical Case Discussions #1
|
9/30/2025
|
LIVE Session: Review of Clinical Case Applications Covered in Lectures 1 – 4
|
|
1.5
|
|
Pain
|
10/7/2025
|
Lecture 5: Opioids and NSAIDs
|
1
|
|
|
Infectious Diseases & Transplant
|
10/7/2025
|
Lecture 6: Voriconazole, atazanavir, efavirenz, tacrolimus, and abacavir
|
1
|
|
|
Gastroenterology
|
10/7/2025
|
Lecture 7: PPIs and ondansetron
|
1
|
|
|
Oncology
|
10/14/2025
|
Lecture 8: Mercaptopuriine, azathioprine, fluoropyrimidines, irinotecan, tamoxifen, rasburicase
|
2
|
|
|
Applied Clinical Case Discussions #2
|
10/21/2025
|
LIVE Session: Review of Clinical Case Applications Covered in Lectures 5 – 8
|
|
1.5
|
|
Behavioral Health
|
10/28/2025
|
Lecture 9: SSRIs, SNRIs, TCAs, Antipsychotics
|
2
|
|
|
Neurology
|
10/28/2025
|
Lecture 10: Siponimod, pimozide, brivaracetam, clobazam, deutetrabenazine, pitolisant, tetrabenazine, valbenazine
|
1
|
|
|
Applied Clinical Case Discussions #3
|
11/4/2025
|
LIVE Session: Review of Clinical Case Applications Covered in Lectures 9 – 10
|
|
1.5
|
|
Clinical Implementation (Part 1)
|
11/11/2025
|
Lecture 11: How to build a program: Planning and Stakeholder Engagement; Program Design; Education and Training
|
1
|
|
|
Clinical Implementation (Part 2)
|
11/11/2025
|
Lecture 12: How to build a program: Pilot Implementation; Evaluation and Scaling; Sustainability
|
1
|
|
|
PGx in Action: Real-World Implementation of Pharmacogenomics
|
11/18/2025
|
Lecture 13: This lecture will highlight up to two real-world pharmacogenomics (PGx) programs, focusing on program goals, stakeholder roles, key challenges, lessons learned, and successes in clinical integration.
|
“Non-CE Lecture”
|
1.5
|
|
Cost effectiveness / Reimbursement / ELSI
|
11/18/2025
|
Lecture 14
|
1
|
|
|
Clinical Implementation Discussion
|
11/25/2025
|
LIVE Session: Review of Individual Implementation Plans based on the content Covered in Lectures 11 - 14
|
|
1.5
|
Domain 1 – Knowledge
1.1 Scientific Thinking
- Objectives: 1, 2, 3, 4, 5, 6, and 7
Domain 2 – Skills
2.1. Problem-solving Process
2.2 Communication
- Objectives: 1, 2, 3, 4, and 7
2.4 Person-centered Care
- Objectives: 2, 3, 4, 5, 6, and 7
2.7 Interprofessional Collaboration
- Objectives: 3, 4, 7, and 9
Domain 3 – Attitudes
3.2. Professionalism
A computer with a high speed internet connection and audio is necessary. A webcam is preferred, but not required. An up-to-date internet browser (e.g., Chrome, Safari, Edge, FireFox) and Zoom conferencing software is required. For additional information about requirements to participate in Zoom sessions visit https://support.zoom.us/hc/en-us/articles/201362023-System-requirements-for-Windows-macOS-and-Linux.
A combination of home study exercises, assessments, and ‘live’ virtual case-based sessions will encourage participants to achieve the outcomes of the program.
The learning management system will be accessible through registrants “My Account” page on https://accp.com. The ‘live’ virtual sessions will be delivered via Zoom.
 |
Aniwaa Owusu Obeng, Pharm.D. ACCP Program Director, ACCP Precision Medicine: Applied Pharmacogenomics Certificate Program Senior Director, Mount Sinai Pharmacogenomics Program, Mount Sinai Health System Associate Professor, Icahn School of Medicine at Mount Sinai Phone 212-241-7371, Email: [email protected]
|
 |
Jeffrey R. Bishop, Pharm.D., MS, FCCP, BCPP Professor, Department of Experimental and Clinical Pharmacology (ECP) Adjunct Associate Professor, Department of Psychiatry The University of Minnesota Phone: 612-625-5435, Email: [email protected]
|
 |
Teresa T. Ho, Pharm.D., BCPS Precision Medicine Specialist Moffitt Cancer Center Email: [email protected]
|
Program faculty, led by Program Director Aniwaa Owusu Obeng, developed the curriculum to address the Program outcomes. Faculty divided content presentations according to their respective areas of expertise/practice. Presentations, practice opportunities, assessments, and feedback were all developed by the faculty to maximize practice opportunities and active learning.
Throughout the entire program, the instructors are available by email or phone to answer questions and provide feedback.
Content and learning materials will be reviewed prior to and after each offering of the Activity.
Electronic Program Evaluations will be performed at the conclusion of the program and required prior to issuing certificates and CPE.
To receive continuing pharmacy education credit and a certificate of completion, participants must complete all self-study lecture-based assessments and receive 70% or better on each, receive 80% or better on the cumulative final exam, and attest to attending all ‘live’ virtual sessions. Two attempts will be allowed for the final course examination.
See the separate schedule for weekly details and due dates. The activities and assessments in this program include:
- Pre-Program Inventory:
- Deadline: Monday, September 8th, 2025 by 11:59pm EST.
- All participants are required to complete the online Pre-Program Assessment.
- Note: This assessment is not graded and is intended to establish baseline knowledge.
- Pre-recorded Lectures:
- New lectures will be released on specified Tuesdays, as outlined in the course schedule.
- Participants are expected to review all assigned lectures and submit responses to lecture-specific assessment questions to confirm completion prior to each associated live “Applied Clinical Case Discussion” session.
- Live Virtual Sessions (Remote Learning):
- Attendance and active participation in all six (6) hours of ‘live’ virtual Applied Clinical Case Discussion is required.
- These sessions provide interactive, case-based discussions designed to reinforce and apply content from the pre-recorded lectures.
- Post-Program Inventory:
- Participants will be asked to complete an online Post-Program Assessment to evaluate knowledge gained. Like the pre-program inventory this is not graded.
- Additional details and deadlines will be provided during the program.
- Final Examination:
- Deadline: Friday, December 19, 2025 by 11:59pm EST.
- Participants must pass the online Final Course Exam with a minimum score of 80% to receive the certificate of completion.
Successful completion of all of the requisites no later than December 19, 2025 will provide 22.0 contact hours of practice-based continuing pharmacy education (6 hours live and 16 hours home-study) and a certificate delivered by email.
To achieve the stated program outcomes the activity is designed to be completed in its entirety. No continuing education credit will be given for partial completion of the activity.
For participants successfully completing all requirements of the program, CE hours will be submitted online via CPE Monitor®. In order for ACCP to submit credit to CPE Monitor, the participants’ ACCP.com profile must contain their NABP eProfile ID and birthdate.
Initial release date: September 9, 2025
Expiration date: December 19, 2025
|
Registration Rates
|
Member
|
Non-Member
|
|
Precision Medicine: Applied Pharmacogenomics Program Registration
|
$395
|
$695
|
|

|
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.
Participation in this program will follow and be protected by the privacy policy of the American College of Clinical Pharmacy. This policy may be reviewed at https://www.accp.com/about/privacy.aspx.
For questions about this Internet CPE activity please contact [email protected].